Real Time Surveillance of Pediatric Infectious Diseases in French Ambulatory Care: PARI Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 400,000
- Locations
- 1
- Primary Endpoint
- Evaluation of the number of infectious diseases
Study Overview
Brief Summary
Many ambulatory networks are mainly based on diagnoses made by first-line physicians not specifically trained to join the network. Here we aim to set up a surveillance network on pediatric infectious diseases with an investment in teaching with specific trainings of participating pediatricians, increasing in use of point of care tests, and automated data extraction from the computers of the pediatricians.
Detailed Description
107 pediatricians among the 1400 members of the French ambulatory pediatric association, AFPA (Association Française de Pédiatrie Ambulatoire) were involved in this survey.To belong to the PARI network, pediatricians have to use the same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France) for electronic medical record of children. The pediatricians were trained to the use of point of care tests and to the infectious diagnoses (otitis, pharyngitis, varicella, bronchiolitis, influenza, pneumonia, etc..). The study population consisted of all children under 16 years of age from the patient population for which an infectious disease was diagnosed.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 1 Day to 16 Years (Child)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Children under 16 years of age with at least one infectious disease among:
- •pharyngitis
- •pneumonia
- •influenza
- •bronchiolitisz
- •varicella
- •gastroenteritis
- •enterovirus disease
- •bordetella pertussis disease
- •using the same same software, Axi5-Infansoft (developed by CompuGroup Medical, Nanterre, France)
Exclusion Criteria
- •parental refusal
Outcomes
Primary Outcomes
Evaluation of the number of infectious diseases
Time Frame: 5 years
proportion of children under 16 years, with infectious disease
Secondary Outcomes
- Evaluation of the antibiotic treatments(5 years)
- Evaluation of the use of point of care tests(5 years)